Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection (Q101453899)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

title

Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

1 reference

0 references

10

David S Liebeskind

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

author name string

Naoki Kaneko

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

Sandro Satta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

Yutaro Komuro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

Sree Deepthi Muthukrishnan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

Visesha Kakarla

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

Lea Guo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

Jennifer An

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

Fanny Elahi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

Harley I Kornblum

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

Tzung Hsiai

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

Jason D Hinman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

publication date

9 November 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

page(s)

STROKEAHA120032764

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature

11 November 2020

cites work

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Stroke in patients with SARS-CoV-2 infection: case series

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Endothelial cell infection and endotheliitis in COVID-19

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Cytokine storm intervention in the early stages of COVID-19 pneumonia

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Immunomodulation in COVID-19

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Upregulation of angiotensin converting enzyme 2 by shear stress reduced inflammation and proliferation in vascular endothelial cells

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

COVID-19: the vasculature unleashed

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Manufacture of patient-specific vascular replicas for endovascular simulation using fast, low-cost method

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Functions of IL-15 in anti-viral immunity: multiplicity and variety

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Neutrophil polarization by IL-27 as a therapeutic target for intracerebral hemorrhage

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination.

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex.

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Neurologic complications of COVID-19

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

A patient-specific intracranial aneurysm model with endothelial lining: a novel in vitro approach to bridge the gap between biology and flow dynamics

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Complement component C3 mediates inflammatory injury following focal cerebral ischemia.

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

ACE2 activity was increased in atherosclerotic plaque by losartan: Possible relation to anti-atherosclerosis.

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

SARS-CoV-2-Associated Acute Hemorrhagic, Necrotizing Encephalitis (AHNE) Presenting with Cognitive Impairment in a 44-Year-Old Woman without Comorbidities: A Case Report

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

EndoDB: a database of endothelial cell transcriptomics data

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

6 November 2021

1 reference

https://api.crossref.org/works/10.1161/STROKEAHA.120.032764

10.1161/STROKEAHA.120.032764

6 November 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33161843%20AND%20SRC:MED&resulttype=core&format=json

11 November 2020

0 references

1 reference